Skip to content

UVB: Skin to Gut Study

Intestinal Microbiota Changes After Ultra Violet Radiation B Exposure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03962673
Enrollment
23
Registered
2019-05-24
Start date
2018-02-19
Completion date
2019-02-26
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Phototherapy, Microbiome, Vitamin D

Brief summary

This research will explore the potential effects of Narrow-Band Ultra Violet B (NB-UVB) radiation on the intestinal microbiota composition and confirm a regulatory skin-to-gut axis during baseline conditions. Changes in the intestinal microbiota composition caused by NB-UVB phototherapy could be beneficial for patients with chronic/auto-inflammatory diseases like inflammatory bowel disease (IBD) by removing dangerous bacteria, increasing beneficial bacteria, and ultimately modulating immune responses.

Detailed description

Purpose: To explore the potential effects of Narrow-Band Ultra Violet B (NB-UVB) radiation on the intestinal microbiota composition in humans and confirm a regulatory skin-to-gut axis during baseline conditions. Hypothesis: Humans exposed to UVB-NB light will show changes in the intestinal microbiota composition with the selection of certain phyla of bacteria. Justification: To date, there is no data that describes a biological response to UVB light in the body that affects the intestinal microbiota. Changes in the intestinal microbiota composition caused by NB-UVB phototherapy could be beneficial for patients with chronic/auto-inflammatory diseases like IBD by removing dangerous bacteria, increasing beneficial bacteria, and ultimately modulating immune responses. Objectives: 1. Establish if there is a skin regulatory response towards NB-UVB light in humans. 2. Examine what changes in the microbiota composition can be observed on bacterial phyla and class level. 3. Determine if this research is worth pursuing in a larger cohort. Research design: During the first visit, the skin type will be assessed by using the Fitzpatrick skin type questionnaire. Subsequently, subjects will be exposed three times within one week to full body NB-UVB light in The Skin Care Centre to a sub erythemic dose (cause slight redness of the skin but not burning). The exposures will happen during the winter months to prevent UVB exposure from the sun during daily activities to interfere with our observations. Stool samples will be collected before the first exposure (2x) and after the last exposure (2x) to analyze the microbiota composition. Also, serum vitamin D (25-hydroxy vitamin D) will be measured before and after the UVB exposure as a marker of previous UVB exposure before the experiment.

Interventions

RADIATIONNB-UVB light exposure

Participants are exposed to three low dose Narrow Band UVB light.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants are receiving the same treatment of which the UVB dose is adjusted for the participants Fitzpatrick skin type.

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Caucasian females * Fitzpatrick skin type I, II or III

Exclusion criteria

* Skin photosensitivity due to medication * Been on vacation to a sunny destination three months before enrollment * Visit tanning beds on a regular basis in the past

Design outcomes

Primary

MeasureTime frameDescription
MicrobiomeBefore and after the UVB exposures (1 week apart)Changes in the fecal microbiome composition after the UVB light exposures
Serum vitamin D1 weekThe effect of UVB light exposures on the serum vitamin D concentrations

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026